Close
American Drug Delivery & Formulation Summit
Xylem

Featured

NSF-funded Smartphone COVID-19 Diagnostic Test Could Put Testing in the Hands of the Public

A smartphone diagnostic test for COVID-19 being developed by a University of Utah researcher holds the potential for quick, accurate testing without the need for individuals to go to a healthcare facility. A prototype may be ready within two...

Sterling Pharma Solutions commence the production of potential COVID-19 treatment

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19. Sterling will be manufacturing the active pharmaceutical ingredient (API) with the finished product being manufactured and supplied...

Abbott Earns Emergency Use Authorization for Another COVID-19 Antibody Test

Abbott Laboratories has won Emergency Use Authorization for another COVID-19-related diagnostics test for antibodies. This morning, the company said the U.S. Food and Drug Administration approved its SARS-CoV-2 IgG lab-based serology blood test on the Alinity i system. With the...

Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval from Indiaโ€™s drug regulator DCGI in late April. Glenmark is the first company in...

Oliver Healthcare Packaging clinches Packaging Design of the Year Award

Singaporeโ€™s Oliver Healthcare Packaging received the Packaging Design of the Year Award at the recently concluded Healthcare Asia Pharma Awards 2020. The award recognised the companyโ€™s proprietary Autoclavable Dispos-a-ventยฎ Barrier Pouch, which provides medical device manufacturers a pouch option for...

INOVIO Expands Manufacturing of COVID-19 DNAVaccine INO-4800 With New Funding from CEPI

INOVIO announced it has entered into an agreement to expand its manufacturing partnership with the German contract manufacturer Richter-Helm BioLogics GmbH & Co. KG, to support large-scale manufacturing of INOVIO's investigational DNA vaccine INO-4800, which currently is in Phase...

Massachusetts Hospital to Assess Mallinckrodt’s Nitric Oxide Treatment for COVID-19

Mallinckrodt and Massachusetts General Hospital teamed up to evaluate the potential benefits of inhaled nitric oxide as a treatment for pulmonary complications in patients infected with COVID-19. The partnership will assess the benefit of INOmax (nitric oxide) gas in mechanically...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป